Stockreport

Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Report Preview: What to Expect [Yahoo! Finance]

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com
PDF The consensus estimate for Q2 2025 revenue is $0.22 million, and the earnings are expected to come in at -$0.39 per share. The full year 2025's revenue is expected to be [Read more]